MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s40249-025-01296-7

Медицинская библиотека · Infectious diseases of poverty · 2025

Recombinant Leishmania-activated C kinase as a novel antigenic candidate for immuno-diagnosis of visceral leishmaniasis occurring in India and Brazil.

Bhattacharyya Anirban, Didwania Nicky, Ejazi Sarfaraz Ahmad, Chhajer Rudra, Gayen Saswati, Rahman Mehebubar, Goswami Rama Prosad, Pandey Krishna, Das Vidya Nand Ravi, Das Pradeep, da Silva Fernando Oliveira, Costa Dorcas Lamounier, Costa Carlos Henrique Nery, Ali Nahid

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

Visceral leishmaniasis (VL) an 'infectious disease of poverty', caused by the Leishmania donovani complex, remains a significant public health threat in endemic regions of South Asia, East Africa, and Brazil. Early and accurate diagnosis is critical to prevent the disease's potentially fatal outcomes. However, due to the nonspecific nature of clinical symptoms, diagnosis often relies on serological tests. This study aims to assess the diagnostic potential of the L. donovani activated C kinase (LACK), a highly conserved antigen essential for parasite survival and host establishment, in VL-endemic regions such as India and Brazil.

METHODS

We conducted a multi-center study with serum samples from India (n = 184) and Brazil (n = 59), along with non-invasive urine samples from India (n = 132). Clinical samples from India were collected from the endemic regions of Bihar and West Bengal between 2016-2024, while those from Teresina, Brazil, were collected between 2008 and 2009. Following preliminary immunoblot analysis, we validated the diagnostic utility of LACK through enzyme-linked immunosorbent assays (ELISA) and dipstick tests. Results were analyzed and area under a Receiver Operating Characteristic (ROC) curve (AUC) values were calculated via the Mann-Whitney U test. Additionally, sensitivity, specificity, and confidence intervals were assessed to evaluate diagnostic performance.

RESULTS

The ELISA results revealed that LACK antibodies exhibited 100% sensitivity in both Indian [95% confidence intervals (CI): 94.80-100%] and Brazilian (95% CI: 91.24-100%) patient samples, with specificity of 97.33% for Indian controls and 94.74% for Brazilian controls. Urine samples from Indian patients also demonstrated perfect sensitivity and specificity (100%). Notably, LACK showed minimal reactivity with follow-up patient samples. Dipstick assays confirmed these findings, offering a simple, rapid, and field-friendly diagnostic alternative.

CONCLUSION

LACK is a promising diagnostic marker for VL, showing high sensitivity across regions and has potential to distinguish active infections from cured or relapsed cases, though larger studies are needed for confirmation.

Для цитирования: Bhattacharyya Anirban, Didwania Nicky, Ejazi Sarfaraz Ahmad, Chhajer Rudra, Gayen Saswati, Rahman Mehebubar, Goswami Rama Prosad, Pandey Krishna, Das Vidya Nand Ravi, Das Pradeep, da Silva Fernando Oliveira, Costa Dorcas Lamounier, Costa Carlos Henrique Nery, Ali Nahid. Recombinant Leishmania-activated C kinase as a novel antigenic candidate for immuno-diagnosis of visceral leishmaniasis occurring in India and Brazil.. Infectious diseases of poverty. 2025. DOI: 10.1186/s40249-025-01296-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.